KENTUCKY: Attorney Generals Office: The settlement resolves allegations that Wyeth unlawfully promoted Rapamune, an immunosuppressive drug currently approved by the FDA to counteract organ rejection after kidney transplant surgery. The judgment, filed today, alleges that Wyeth violated state consumer protection laws by misrepresenting the uses and benefits of Rapamune, including making representations related to: (1) the unapproved use of Rapamune following an organ transplant other than a kidney transplant; (2) the unapproved protocol of converting patients to Rapamune after initially receiving a different immunosuppressive drug; and (3) using Rapamune in unapproved drug combinations. See more... migration.kentucky.gov/Newsroom/ag/phizersettlement.htm
Posted on: Thu, 07 Aug 2014 02:12:27 +0000